Limitations, agreements, and source contact

Effect of Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Relapsed After 1-3 Prior Lines of Therapy · Source last updated 2014-08-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

restrictive Agreement

false

point Of Contact

email

mdimop@med.uoa.gr

organization

Department of Clinical Therapeutics, University of Athens School of Medicine, "Alexandra" General Hospital of Athens,

phone

0030 210 3381511

title

Prof. M. A. Dimopoulos

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice